Addleshaw Goddard's Yorkshire Corporate team has advised private equity house, Key Capital Partners (KCP), on its majority investment of over £8m, backing the management team of YorkTest Laboratories Limited (YorkTest) in completing an MBO that sees CBPE Capital sell its entire stake in the food intolerance testing business.
YorkTest, which also trades as Lorisian, is the leading player in the UK's food intolerance and allergy testing market, offering comprehensive services, such as: finger-prick blood testing and laboratory analysis to determine food and drink intolerance; and the provision of specialist nutritional advice and consultancy to customers.
The investment from KCP, is the latest in the firm's investment into high growth businesses across the UK and enables the company to further accelerate its growth into global markets.
YorkTest, which has a long-established UK direct customer base, has seen a growth in sales overseas through its Lorisian brand, due to demand from a series of business partners, including: a network of nutritionists; and Healthcare, Insurance and Occupational Health blue-chip customers.
The AG team who advised on the deal comprised of: Yunus Seedat, Adam Kaucher, Matthew Davies, Ben Collins and Caera Loughran.